Ameriprise’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-567,759
| Closed | -$29.8M | – | 3902 |
|
|
2020
Q3 | $29.8M | Buy |
567,759
+14,314
| +3% | +$593K | 0.01% | 871 |
|
|
2020
Q2 | $18.4M | Sell |
553,445
-3,833
| -0.7% | -$122K | 0.01% | 1102 |
|
|
2020
Q1 | $15.2M | Sell |
557,278
-21,760
| -4% | -$606K | 0.01% | 1116 |
|
|
2019
Q4 | $11.4M | Buy |
579,038
+56,896
| +11% | +$910K | ﹤0.01% | 1636 |
|
|
2019
Q3 | $6.77M | Sell |
522,142
-15,715
| -3% | -$190K | ﹤0.01% | 1997 |
|
|
2019
Q2 | $6.7M | Sell |
537,857
-16,090
| -3% | -$214K | ﹤0.01% | 2025 |
|
|
2019
Q1 | $8.05M | Buy |
553,947
+7,188
| +1% | +$91.8K | ﹤0.01% | 1891 |
|
|
2018
Q4 | $6.04M | Buy |
546,759
+26,606
| +5% | +$370K | ﹤0.01% | 1995 |
|
|
2018
Q3 | $13.7M | Buy |
520,153
+27,204
| +6% | +$735K | ﹤0.01% | 1615 |
|
|
2018
Q2 | $10.1M | Sell |
492,949
-191,861
| -28% | -$4.12M | ﹤0.01% | 1729 |
|
|
2018
Q1 | $12.4M | Sell |
684,810
-82,150
| -11% | -$1.37M | 0.01% | 1492 |
|
|
2017
Q4 | $10.7M | Buy |
766,960
+30,892
| +4% | +$418K | ﹤0.01% | 1562 |
|
|
2017
Q3 | $13.6M | Buy |
736,068
+44,290
| +6% | +$740K | 0.01% | 1338 |
|
|
2017
Q2 | $11.7M | Buy |
691,778
+350,112
| +102% | +$5.33M | 0.01% | 1420 |
|
|
2017
Q1 | $4.56M | Buy |
341,666
+18,174
| +6% | +$285K | ﹤0.01% | 2116 |
|
|
2016
Q4 | $4.87M | Sell |
323,492
-7,050
| -2% | -$93.1K | ﹤0.01% | 2069 |
|
|
2016
Q3 | $3.86M | Buy |
330,542
+6,040
| +2% | +$71K | ﹤0.01% | 2175 |
|
|
2016
Q2 | $3.5M | Buy |
324,502
+19,193
| +6% | +$198K | ﹤0.01% | 2198 |
|
|
2016
Q1 | $2.82M | Buy |
305,309
+2,393
| +0.8% | +$25.7K | ﹤0.01% | 2321 |
|
|
2015
Q4 | $4.49M | Sell |
302,916
-7,623
| -2% | -$128K | ﹤0.01% | 2084 |
|
|
2015
Q3 | $5.1M | Sell |
310,539
-79,483
| -20% | -$1.63M | ﹤0.01% | 1996 |
|
|
2015
Q2 | $8.89M | Buy |
390,022
+143,308
| +58% | +$2.85M | 0.01% | 1704 |
|
|
2015
Q1 | $3.75M | Buy |
246,714
+22,486
| +10% | +$292K | ﹤0.01% | 2246 |
|
|
2014
Q4 | $2.7M | Buy |
224,228
+989
| +0.4% | +$11.3K | ﹤0.01% | 2409 |
|
|
2014
Q3 | $2.53M | Buy |
223,239
+15,540
| +7% | +$177K | ﹤0.01% | 2409 |
|
|
2014
Q2 | $2.51M | Buy |
207,699
+8,473
| +4% | +$100K | ﹤0.01% | 2443 |
|
|
2014
Q1 | $2.32M | Buy |
199,226
+3,758
| +2% | +$63.6K | ﹤0.01% | 2421 |
|
|
2013
Q4 | $3.46M | Buy |
195,468
+19,322
| +11% | +$325K | ﹤0.01% | 2217 |
|
|
2013
Q3 | $2.53M | Buy |
176,146
+6,230
| +4% | +$95.3K | ﹤0.01% | 2329 |
|
|
2013
Q2 | $2.56M | Buy |
+169,916
| New | +$2.24M | ﹤0.01% | 2246 |
|
Ameriprise's MNTA Position: Q4 2020 in Review
Ameriprise sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 567,759 shares — an estimated $29.8M sold.
Ameriprise first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $29.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Ameriprise reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Ameriprise sold 567,759 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $29.8M.
- Ameriprise first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Ameriprise's Momenta Pharmaceuticals, Inc. position peaked at $29.8M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.